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Abstract 
Purpose: To study the prevalence of Neisseria gonorrhoeae in the high vaginal swab samples of fertile 
and infertile women who were referred to Infertility and Sterility Hospitals, Tehran, Iran as well as 
investigate their antibiotic resistance pattern.  
Methods: Three hundred and twenty high vaginal swabs were taken from fertile and infertile women. 
The samples were cultured and those that were N. gonorrhoeae-positive subjected to the disk diffusion 
susceptibility test.  
Results: Prevalence of N. gonorrhoeae in fertile and infertile women were 5.26 and 16.92 %, 
respectively. All isolates harbored orf1 gene. Patients in the age bracket > 40 years were at high risk. N. 
gonorrhoeae strains showed high level resistance against ampicillin (87.5 %), ciprofloxacin (75 %), 
tetracycline (71.87 %) and penicillin (68.75 %).  
Conclusion: The possible role of resistant N. gonorrhoeae as pathogens causing female infertility 
constitutes an important finding of the study. The high levels of bacterial resistance against ampicillin, 
ciprofloxacin, tetracycline, penicillin and spectinomycin, should be taken into account in developing any 
new guidelines in the management of the infection. 
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INTRODUCTION 
 
Infertility is one of the major serious concerns 
confronting medical practitioners. Despite all the 
advances in medical sciences, the main reasons 
of infertility especially in women are still 
unknown. Infertility means that couples have 
been trying to get pregnant with frequent 
interaction for at least a year with no 
achievement [1,2]. It has been estimated that 
about 72.4 million couples are infertile [3]. 
Majority of women with infertility problems 
manifest inflammatory changes of the oviduct or 
surrounding peritoneum. Most of these 
alterations result from infections [4]. 
 
Neisseria gonorrhoeae (the gonococcus) is a 
Gram-negative diplococcal bacterium which 
infects only humans. It causes gonorrhea, 
sexually transmitted infections (STI), Pelvic 
Inflammatory Disease (PID), ectopic pregnancy, 
chronic pelvic pain, infertility, acute urethritis, 
cervicitis and proctitis or pharyngitis [5]. N. 
gonorrhoeae infections represent 106 million of 
the estimated 498 million new cases of curable 
sexually transmitted infection that occur globally 
every year [5]. Previous studies have estimated 
3.4 million cases of gonorrhea among adults in 
the European countries [5]. 
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One of the best therapeutic options for treatment 
of the cases of gonorrhea caused by this 
bacterium is antibiotic therapy. However, 
antibiotic-resistant N. gonorrhoeae have evolve 
and spread rapidly [6]. N. gonorrhoeae 
resistance is commonly observed with penicillin, 
tetracycline and fluoroquinolones antibiotics [6]. 
Resistance has also emerged against cefixime, 
an oral third generation cephalosporin, in recent 
years [7,8]. Since 2010, cefixime has not been 
recommended as first-line drug treatment [7,8] 
following WHO guidelines, stating that an 
antibiotic should not be used when more than 5 
% of N. gonorrhoeae isolates are resistant [9]. 
Injectable ceftriaxone, in combination with oral 
azithromycin, are the recommended first line 
drug treatment [10]. Data regarding the 
epidemiology, prevalence of antibiotic resistance 
profile of N. gonorrhoeae in the cases of female 
infertility is scarce in Iran. Therefore, the present 
investigation was carried out to study the 
prevalence of N. gonorrhoeae in the high vaginal 
swab samples of fertile and infertile women as 
well as investigate the antibiotic resistance 
pattern of bacterial isolates.  
 
EXPERIMENTAL  
 
Ethical issues 
 
The aspect of human studies in the present study 
was approved by the ethical committee of 
Department of Infertility and Sterility of 
Educational Hospitals, Iran (approval ref no. 
20275 MD), and the Research Adjutancy of Hajar 
Hospital, Tehran, Iran (approval ref no. 45891 
MD). The authors conformed to generally 
accepted scientific principles [11]. All samples 
were taken from volunteer women who were 
referred to Infertility and Sterility Hospitals, Iran. 
Written consents were obtained from the infertile 
and fertile women or their husbands. 
 
Sample collection 
 
Samples were collected from June to November 
2015; a total of 130 high vaginal swab specimens 
were taken from infertile women. In a primary 
view, a woman after a year of regular intercourse 
without prevention was defined as infertile. 
Vaginal specimens were collected from the 
ventral fornix without any contact with urine and 
external parts of reproductive system using 
speculum and commercial sterile cotton-tipped 
swabs. All specimens were collected by an 
expert midwife. One hundred and ninety vaginal 
swab specimens were also collected from fertile 
women with no history of infertility.  
 
Culture-based identification of N. 
gonorrhoeae 
 
All the samples were inoculated directly onto 
modified Thayer Martin (Thayer Martin + laked 
sheep blood and the antibiotic supplement (BBL 
VCNT inhibitor) including colistin (750 µg), 
nystatin (1250 units), vancomycin (300 µg) and 
trimethoprim Lactate (500 µg)) and incubated 
immediately at 34 to 36 °C in an atmosphere of 5 
% CO2 for 72 h. Morphologically suggestive 
colonies were screened by Gram staining and by 
their positive responses to the oxidase and 
catalase tests. Positive colonies were 
subcultured on chocolate supplement agar 
(Chocolate Polyvitex/Biomérieux®), and their 
identification confirmed by fluorescent-antibody 
staining (Baxter Scientific, McGaw Park, Ill). 
 
DNA extraction and PCR confirmation of 
positive colonies 
 
Genomic DNA was extracted from the bacterial 
colonies using the commercial genomic DNA 
extraction kit (Fermentas, Germany) according to 
the manufacturer’s instruction. The DNA 
concentration has been determined by 
measuring absorbance of the sample at 260 nm 
using spectrophotometer [12]. Presence of N. 
gonorrhoeae was confirmed with the PCR-based 
amplification of orf1 gene. Reaction was 
performed in a final volume of 50 µL containing 5 
µL 10 × buffer + MgCl2, 2 mM dNTP, 2 unit Taq 
DNA polymerase, 100 ng genomic DNA as a 
template, and 25 picomole of each primer (5'-
CAACTATTCCCGATTGCGA-3’ and 5'- 
GTTATACAGCTTCGCCTGAA-3') (amplify the 
221–480 bp region of orf1 gene). PCR was 
performed using a thermal cycler (Eppendorf 
Mastercycler 5330, Eppendorf-Nethel-Hinz 
GmbH, Hamburg, Germany) under the following 
conditions: an initial denaturation for 10 min at 94 
°C and 40 cycles including 94 °C for 30 s, 52 °C 
for 30 s and 72 °C for 1 min, and a final 
extension at 72 °C for 5 min. S. aureus ATCC 
19424 was used as a positive control and 
distilled water was used as a negative control. 
PCR amplification products (15 μl) were 
subjected to electrophoresis in a 2 % agarose gel 
in 1X TBE buffer at 80 V for 30 min, stained with 
SYBR Green. 
 
Evaluation of antimicrobial susceptibility 
pattern of N. gonorrhoeae  
 
Pattern of antimicrobial resistance was studied 
using the simple disk diffusion technique. 
Antibiotic resistance of the N. gonorrhoeae 
strains against 9 commonly used antibiotics was 
determined using the Clinical and Laboratory 
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Standards Institute guidelines [20]. Susceptibility 
of N. gonorrhoeae isolates were tested against 
ampicillin (10 µg/disk), azithromycin (15 µg/disk), 
cefixime (5 µg/disk), ceftriaxone (30 µg/disk), 
ciprofloxacin (5 µg/disk), chloramphenicol (30 
µg/disk), penicillin (10 u/disk), tetracycline (30 
µg/disk) and spectinomycin (100 µg/disk) 
antibiotic agents (Oxoid, UK). The diameter of 
the zone of inhibition produced by each antibiotic 
disc was measured and interpreted using the 
CLSI zone diameter interpretative standards [13]. 
N. gonorrhoeae ATCC 49226 was used as a 
standard reference strain for quality control of 
susceptibility testing. 
 
Statistical analysis 
 
The results were transferred to a Microsoft Excel 
spreadsheet (Microsoft Corp., Redmond, WA) for 
analysis. Statistical analysis was performed 
using SPSS/18.0 software (SPSS Inc, Chicago, 
IL) for significant relationship between the 
prevalence of bacteria and their antibiotic 
resistance pattern. The chi-square test and 
Fisher’s exact 2-tailed test analysis were 
performed in this study. Statistical significance 
was regarded at p < 0.05. 
 
RESULTS 
 
Table 1 represents the total prevalence of N. 
gonorrhoeae in fertile and infertile women of 
Iranian infertility and sterility hospitals. Results 
showed that 32 out of 320 high vaginal swab 
samples (10 %) were positive for N. 
gonorrhoeae. Besides, the prevalence of bacteria 
in the high vaginal swab samples of fertile and 
infertile women were 5.26 and 16.92 %, 
respectively. Those older than 40 years old fertile 
(20 %) and infertile (50 %) women had the 
highest prevalence of N. gonorrhoeae.  
Significant statistical differences were seen for 
the prevalence of N. gonorrhoeae between fertile 
and infertile women (p < 0.01). Statistical 
difference was also seen between the age of 
women and prevalence of N. gonorrhoeae (p < 
0.05). All the N. gonorrhoeae strains were 
confirmed using the PCR amplification of orf1 
gene (Figure 1). The N. gonorrhoeae isolates 
were positive for the orf1 gene (Table 1). 
 
 
 
Plate 1: Gel electrophoresis of PCR products for orf1 
gene (260 bp). M: 100 bp ladder, 2: Positive sample 
for the orf1 gene, 2: Positive control and 3: Negative 
control 
 
Table 2 represents the antimicrobial resistance 
pattern of N. gonorrhoeae strains isolated from 
fertile and infertile women of Iranian infertility and 
sterility hospitals. We found that the N. 
gonorrhoeae strains showed high level 
resistance against ampicillin (87.5 %), 
ciprofloxacin (75 %), tetracycline (71.87 %) and 
penicillin (68.75 %). N. gonorrhoeae isolates of 
infertile women were more resistant against 
commonly used antibiotic than those of fertile 
women (p < 0.05). 
 
 
Table 1: Total prevalence of Neisseria gonorrhoeae in fertile and infertile women in infertility and sterility 
hospitals in Tehran, Iran 
 
Type of sample No. of samples collected 
N. gonorrhoeae (N, 
%) 
Orf1 gene-positive 
(%) 
Fertile 
women 
< 20 years 55 1 (1.81) 1 (1.81) 
20-30 years 65 1 (1.53) 1 (1.53) 
30-40 years 45 3 (6.66) 3 (6.66) 
> 40 years 25 5 (20) 5 (20) 
Total 190 10 (5.26) 10 (5.26) 
Infertile 
women 
< 20 years 30 4 (13.33) 4 (13.33) 
20-30 years 50 3 (6) 3 (6) 
30-40 years 30 5 (16.66) 5 (16.66) 
> 40 years 20 10 (50) 10 (50) 
Total 130 22 (16.92) 22 (16.92) 
Total 320 32 (10) 32 (10) 
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Table 2: Antimicrobial resistance pattern of Neisseria gonorrhoeae strains isolated from fertile and infertile 
women of Iranian infertility and sterility hospitals 
 
Type of sample (no. 
positive) Antibiotic resistance pattern (%) 
 AM10
* AZ15 CFX5 CTX30 CIP5 C30 P10 TET30 SPCT100 
Fertile women (10) 7 (70) 1 (10) 2 (20) - 6 (60) - 5 (50) 6 (60) 4 (40) 
Infertile women (22) 21 (95.45) 5 (22.72) 3 (13.63) 2 (9.09) 18 (81.81) 1 (4.54) 17 (77.27) 17 (77.27) 14 (63.63) 
Total (32) 28 (87.5) 6 (18.75) 5 (15.62) 2 (6.25) 24 (75) 1 (3.12) 22 (68.75) 23 (71.87) 18 (56.25) 
*AM10: ampicillin (10 µg/disk), AZ15: azithromycin (15 µg/disk), CFX5: cefixime (5 µg/disk), CTX30: ceftriaxone 
(30 µg/disk), CIP5: ciprofloxacin (5 µg/disk), C30: chloramphenicol (30 µg/disk), P10: penicillin (10 u/disk), 
TET30: tetracycline (30 µg/disk), SPCT100: spectinomycin (100 µg/disk) 
 
DISCUSSION 
 
Infections of the genital tract may be 
predisposing factors in unexplained infertility. 
Hormonal disorders that occurred in infertile 
women can lead to reduced levels of immunity 
and increase bacterial colonization of vaginal 
epithelium [14]. Women follicular fluid is not 
sterile and the levels of cytokines, chemokines 
and growth factors which are essential for 
ovarian function [15], secretion of ovarian steroid 
hormones [15] and development and regression 
of corpus luteum [16] in follicular fluid of infertile 
women have been decreased. Therefore, it is not 
surprising the 16.92 % of high vaginal swab 
samples of infertile women were infected with 
resistant strains of N. gonorrhoeae. The present 
study found high levels of N. gonorrhoeae 
resistance against ampicillin, ciprofloxacin, 
tetracycline, penicillin and spectinomycin. 
 
Several investigations have been done in this 
field all-around the world. Afrasiabi et al [17] 
reported that gonorrhea was diagnosed in 7 out 
of 294 (2.38 %) Iranian women which was lower 
than our results. They showed that the highest 
levels of resistance was observed for 
ciprofloxacin (100 %), penicillin G (100 %), 
ceftriaxone (100 %) and cefepime (100 %), but 
28.5 % of isolates showed intermediate 
sensitivity to tetracycline. Significantly lower 
prevalence of N. gonorrhoeae were also found 
among Iranian previously published research 
[18]. Brunner et al [19] reported that among the 
9097 sexually active patients tested, 582 had an 
N. gonorrhoeae infection (6.39%). The isolates 
were all sensitive to ceftriaxone and 
spectinomycin and 581/582 strains were 
sensitive to cefixime (99.82 %). They also 
showed a high percentage of detected resistance 
to penicillin (77 %), tetracycline (86 %), and 
ciprofloxacin (66 %) which are similar to our 
findings. 
 
In Iran, as is the case in many other countries, 
the control of gonococcal infections mostly 
depended on an effective single-dose antibiotic 
therapy given at the first clinical presentation of 
the patient. Prior knowledge of the antimicrobial 
susceptibility pattern of the particular strain 
infecting the patient was routinely not established 
however. With increasing evidence of 
antimicrobial resistance in gonococcal infections 
there was a real risk of treatment failure and 
development of further resistance to antibiotics.  
 
Unfortunately, irregular and indiscriminate 
prescription of some routine antibiotics including 
ampicillin, ciprofloxacin, tetracycline, penicillin 
and spectinomycin in Iranian infertility and 
sterility hospitals caused high level resistance 
against them. High prevalence of gonococcal 
resistance against these antibiotics has been 
reported previously from United States [20] and 
United Kingdom [21]. Wit was found that 3.12 % 
of N. gonorrhoeae strains were resistant against 
chloramphenicol. Chloramphenicol is only used 
in the final stages of treatment when other 
therapeutic agents are not effective, hence a low 
level of resistance against this antibiotic. 
 
CONCLUSION 
 
The results of this study highlight the role of N. 
gonorrhoeae as a possible pathogens of infertility 
in women, and are a significant contribution to 
current knowledge on antimicrobial susceptibility 
of N. gonorrhoeae strains isolated from cases of 
infertility in Iran. A high level of antimicrobial 
resistance has been found in the isolated strains. 
The emergence of resistance against currently 
recommended antibiotics is worrisome.  
 
Thus, rapid identification of cases of gonococcal 
female infertility, and also primary treatment with 
ceftriaxone, cefixime, and azithromycin, and in 
severe cases with chloramphenicol, may reduce 
the risk of further complications. Monthly check-
up of fertile women and treatment with 
appropriate antibiotics may reduce the risk of 
infertility. Changes in the pattern of antibiotic 
resistance should be taken into account in 
developing any new treatment guidelines for the 
infection. 
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